A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Clinical trial NCT03679767 · COMPLETED

Trial details

NCT number: NCT03679767
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Non-small Cell Lung Cancer Locally Advanced Urothelial Cancer Metastatic Urothelial Cancer Unresectable Melanoma Metastatic Melanoma Locally Advanced Renal Cell Carcinoma Metastatic Clear-Cell Renal Cell Carcinoma

Start date: 2019-01-09
Primary completion: 2021-04-15
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.